Corteva (NYSE:CTVA) Issues FY 2025 Earnings Guidance

Corteva (NYSE:CTVA) issued an update on its FY 2025 earnings guidance on Wednesday morning. The company provided earnings per share (EPS) guidance of 3.000-3.200 for the period, compared to the consensus estimate of 3.140. The company issued revenue guidance of $17.6 billion-$17.8 billion, compared to the consensus revenue estimate of $17.6 billion.

Corteva Trading Down 9.2%

Shares of CTVA stock opened at $61.41 on Thursday. The company has a debt-to-equity ratio of 0.06, a quick ratio of 1.23 and a current ratio of 1.68. The company has a market capitalization of $41.70 billion, a price-to-earnings ratio of 29.95, a PEG ratio of 1.55 and a beta of 0.77. Corteva has a 52-week low of $53.40 and a 52-week high of $77.41. The company has a 50-day simple moving average of $71.64 and a two-hundred day simple moving average of $68.83.

Corteva (NYSE:CTVA) last released its earnings results on Wednesday, August 6th. The company reported $2.20 earnings per share for the quarter, beating analysts’ consensus estimates of $1.89 by $0.31. The firm had revenue of $6.46 billion for the quarter, compared to analysts’ expectations of $6.26 billion. Corteva had a net margin of 8.16% and a return on equity of 8.68%. The company’s quarterly revenue was up 5.6% on a year-over-year basis. During the same period in the previous year, the company earned $1.83 earnings per share. Research analysts anticipate that Corteva will post 2.96 EPS for the current fiscal year.

Corteva Increases Dividend

The company also recently disclosed a quarterly dividend, which was paid on Monday, September 15th. Stockholders of record on Tuesday, September 2nd were given a dividend of $0.18 per share. This is a boost from Corteva’s previous quarterly dividend of $0.17. The ex-dividend date was Tuesday, September 2nd. This represents a $0.72 annualized dividend and a dividend yield of 1.2%. Corteva’s dividend payout ratio is currently 35.12%.

Analyst Upgrades and Downgrades

CTVA has been the subject of a number of recent analyst reports. Oppenheimer set a $87.00 price target on shares of Corteva and gave the company an “outperform” rating in a report on Tuesday, July 15th. Wells Fargo & Company reaffirmed an “overweight” rating and set a $83.00 price objective (up from $82.00) on shares of Corteva in a research note on Friday, August 8th. UBS Group raised their target price on Corteva from $90.00 to $91.00 and gave the stock a “buy” rating in a research note on Thursday, August 7th. Morgan Stanley set a $84.00 price target on Corteva in a report on Monday, September 15th. Finally, KeyCorp increased their price objective on Corteva from $84.00 to $85.00 and gave the stock an “overweight” rating in a report on Friday, August 8th. Thirteen research analysts have rated the stock with a Buy rating and two have given a Hold rating to the stock. According to data from MarketBeat, the company currently has an average rating of “Moderate Buy” and an average target price of $82.00.

Insiders Place Their Bets

In other Corteva news, EVP Robert D. King sold 37,280 shares of Corteva stock in a transaction on Friday, August 29th. The stock was sold at an average price of $74.20, for a total transaction of $2,766,176.00. Following the completion of the transaction, the executive vice president owned 49,262 shares in the company, valued at approximately $3,655,240.40. The trade was a 43.08% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. 0.14% of the stock is currently owned by company insiders.

Hedge Funds Weigh In On Corteva

Several large investors have recently modified their holdings of the stock. AQR Capital Management LLC lifted its stake in Corteva by 409.3% during the 2nd quarter. AQR Capital Management LLC now owns 732,533 shares of the company’s stock valued at $54,456,000 after acquiring an additional 588,708 shares during the period. Canada Pension Plan Investment Board lifted its position in shares of Corteva by 82.0% during the second quarter. Canada Pension Plan Investment Board now owns 748,985 shares of the company’s stock worth $55,822,000 after purchasing an additional 337,407 shares in the last quarter. Lazard Asset Management LLC increased its stake in Corteva by 356.2% in the second quarter. Lazard Asset Management LLC now owns 209,572 shares of the company’s stock valued at $15,618,000 after purchasing an additional 163,634 shares during the last quarter. Cubist Systematic Strategies LLC purchased a new position in shares of Corteva during the second quarter worth approximately $11,519,000. Finally, Brevan Howard Capital Management LP acquired a new stake in Corteva in the second quarter valued at $9,716,000. Hedge funds and other institutional investors own 81.54% of the company’s stock.

Corteva Company Profile

Corteva, Inc operates in the agriculture business. It operates through two segments, Seed and Crop Protection. The Seed segment develops and supplies advanced germplasm and traits that produce optimum yield for farms. It offers trait technologies that enhance resistance to weather, disease, insects, and herbicides used to control weeds, as well as food and nutritional characteristics.